170 related articles for article (PubMed ID: 19847629)
1. Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.
Wolfsegger MJ; Jaki T
J Pharmacokinet Pharmacodyn; 2009 Oct; 36(5):479-94. PubMed ID: 19847629
[TBL] [Abstract][Full Text] [Related]
2. Confidence intervals for ratios of AUCs in the case of serial sampling: a comparison of seven methods.
Jaki T; Wolfsegger MJ; Ploner M
Pharm Stat; 2009; 8(1):12-24. PubMed ID: 18407562
[TBL] [Abstract][Full Text] [Related]
3. Establishing bioequivalence in serial sacrifice designs.
Wolfsegger MJ
J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):103-13. PubMed ID: 17053981
[TBL] [Abstract][Full Text] [Related]
4. Estimation of AUC from 0 to Infinity in Serial Sacrifice Designs.
Wolfsegger MJ; Jaki T
J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):757-66. PubMed ID: 16328101
[TBL] [Abstract][Full Text] [Related]
5. Application of new measures of nonlinearity to parameter estimation and simulations in individual pharmacokinetic analyses.
Khinkis L; Crotzer M
J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):43-52. PubMed ID: 30607795
[TBL] [Abstract][Full Text] [Related]
6. Establishing bioequivalence in complete and incomplete data designs using AUCs.
Jaki T; Wolfsegger MJ; Lawo JP
J Biopharm Stat; 2010 Jul; 20(4):803-20. PubMed ID: 20496207
[TBL] [Abstract][Full Text] [Related]
7. Analysis of pseudo-profiles in organ pharmacokinetics and toxicokinetics.
Mager H; Göller G
Stat Med; 1995 May 15-30; 14(9-10):1009-24. PubMed ID: 7569497
[TBL] [Abstract][Full Text] [Related]
8. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
Knights J; Rohatagi S
J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
[TBL] [Abstract][Full Text] [Related]
9. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
10. New Model-Based Bioequivalence Statistical Approaches for Pharmacokinetic Studies with Sparse Sampling.
Loingeville F; Bertrand J; Nguyen TT; Sharan S; Feng K; Sun W; Han J; Grosser S; Zhao L; Fang L; Möllenhoff K; Dette H; Mentré F
AAPS J; 2020 Oct; 22(6):141. PubMed ID: 33125589
[TBL] [Abstract][Full Text] [Related]
11. [Comparative pharmacokinetic analysis based on nonlinear mixed effect model].
Li LJ; Li XX; Xu L; Lü YH; Chen JC; Zheng QS
Yao Xue Xue Bao; 2011 Apr; 46(4):447-53. PubMed ID: 21751499
[TBL] [Abstract][Full Text] [Related]
12. Optimisation of sampling windows design for population pharmacokinetic experiments.
Ogungbenro K; Aarons L
J Pharmacokinet Pharmacodyn; 2008 Aug; 35(4):465-82. PubMed ID: 18780163
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of population D-optimal designs via pharmacokinetic simulations.
Hooker AC; Foracchia M; Dodds MG; Vicini P
Ann Biomed Eng; 2003 Jan; 31(1):98-111. PubMed ID: 12572660
[TBL] [Abstract][Full Text] [Related]
14. Experimental design and efficient parameter estimation in preclinical pharmacokinetic studies.
Ette EI; Howie CA; Kelman AW; Whiting B
Pharm Res; 1995 May; 12(5):729-37. PubMed ID: 7479560
[TBL] [Abstract][Full Text] [Related]
15. Design and inference for 3-stage bioequivalence testing with serial sampling data.
Yan F; Zhu H; Liu J; Jiang L; Huang X
Pharm Stat; 2018 Sep; 17(5):458-476. PubMed ID: 29726096
[TBL] [Abstract][Full Text] [Related]
16. A comparison of two sparse sampling population pharmacokinetic approaches for the estimation of pharmacokinetic parameters in children.
Mahmood I; Tammara V
Int J Clin Pharmacol Ther; 2004 Apr; 42(4):240-5. PubMed ID: 15124982
[TBL] [Abstract][Full Text] [Related]
17. Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments.
Ogungbenro K; Aarons L; Graham G
J Biopharm Stat; 2006; 16(2):135-50. PubMed ID: 16584063
[TBL] [Abstract][Full Text] [Related]
18. Profile likelihood-based confidence intervals using Monte Carlo integration for population pharmacokinetic parameters.
Funatogawa T; Funatogawa I; Yafune A
J Biopharm Stat; 2006; 16(2):193-205. PubMed ID: 16584067
[TBL] [Abstract][Full Text] [Related]
19. Impact of random and fixed (optimal) sampling approach on the Bayesian estimation of clearance.
Mahmood I
Int J Clin Pharmacol Ther; 2003 Sep; 41(9):392-6. PubMed ID: 14526763
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
